CIM
JAZZ icon

Cambria Investment Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Cambria Investment Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$410K Sell
1,700
-3,229
-66% -$707K 0.02% 545
2026
Q1 		$932K Sell
4,929
-1,131
-19% -$198K 0.05% 246
2025
Q4 		$1.03M Buy
6,060
+171
+3% +$26.2K 0.06% 238
2025
Q3 		$776K Buy
5,889
+391
+7% +$46.9K 0.05% 257
2025
Q2 		$583K Buy
5,498
+3,103
+130% +$337K 0.04% 224
2025
Q1 		$297K Sell
2,395
-1,759
-42% -$229K 0.02% 302
2024
Q4 		$512K Hold
4,154
– – 0.03% 227
2024
Q3 		$463K Buy
4,154
+314
+8% +$34.4K 0.03% 189
2024
Q2 		$410K Sell
3,840
-552
-13% -$60.7K 0.03% 206
2024
Q1 		$529K Sell
4,392
-1,558
-26% -$191K 0.03% 198
2023
Q4 		$732K Hold
5,950
– – 0.05% 149
2023
Q3 		$770K Hold
5,950
– – 0.06% 143
2023
Q2 		$738K Sell
5,950
-782
-12% -$105K 0.06% 145
2023
Q1 		$985K Sell
6,732
-748
-10% -$111K 0.08% 141
2022
Q4 		$1.19M Buy
7,480
+374
+5% +$54.8K 0.1% 161
2022
Q3 		$947K Sell
7,106
-374
-5% -$56.9K 0.1% 143
2022
Q2 		$1.17M Hold
7,480
– – 0.15% 135
2022
Q1 		$1.16M Sell
7,480
-1,317
-15% -$191K 0.15% 137
2021
Q4 		$1.12M Sell
8,797
-657
-7% -$86.3K 0.19% 139
2021
Q3 		$1.23M Buy
9,454
+438
+5% +$66.2K 0.23% 137
2021
Q2 		$1.6M Buy
+9,016
New +$1.56M 0.28% 134

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Cambria Investment Management's JAZZ Position: Q2 2026 in Review

Cambria Investment Management reduced its Jazz Pharmaceuticals (JAZZ) stake by 66% in Q2 2026, selling an estimated $707K and leaving 1,700 shares worth $410K. The position accounts for 0.02% of the portfolio, ranked #545.

Cambria Investment Management first reported a position in JAZZ in Q2 2021 and has held it in 21 quarters since. The position peaked at $1.6M in Q2 2021. 647 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Cambria Investment Management held 1,700 shares of Jazz Pharmaceuticals worth $410K as of Q2 2026.
  • Cambria Investment Management sold 3,229 Jazz Pharmaceuticals shares in Q2 2026, an estimated $707K.
  • Jazz Pharmaceuticals made up 0.02% of Cambria Investment Management's portfolio in Q2 2026, its #545 holding.
  • Cambria Investment Management first reported a position in Jazz Pharmaceuticals in Q2 2021 and has held it in 21 quarters since.
  • Cambria Investment Management's Jazz Pharmaceuticals position peaked at $1.6M in Q2 2021.
  • 647 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Cambria Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.